P218 [Ligand Id: 9740] activity data from GtoPdb and ChEMBL

Click here for a description of the charts and data table

Please tell us if you are using this feature and what you think!

ChEMBL ligand: CHEMBL3040038
  • Dihydrofolate reductase in Plasmodium falciparum K1 [ChEMBL: CHEMBL1939] [UniProtKB: P13922]
  • dihydrofolate reductase/Dihydrofolate reductase in Human [ChEMBL: CHEMBL202] [GtoPdb: 2603] [UniProtKB: P00374]
There should be some charts here, you may need to enable JavaScript!
There should be some charts here, you may need to enable JavaScript!
  • Plasmodium falciparum bifunctional dihydrofolate reductase-thymidylate synthase in Plasmodium falciparum TM4 [GtoPdb: 2981]
  • Plasmodium falciparum bifunctional dihydrofolate reductase-thymidylate synthase in Plasmodium falciparum [GtoPdb: 2981]
  • Plasmodium falciparum bifunctional dihydrofolate reductase-thymidylate synthase in Plasmodium falciparum NF54 [GtoPdb: 2981]
  • Plasmodium falciparum bifunctional dihydrofolate reductase-thymidylate synthase in Plasmodium vivax [GtoPdb: 2981]
There should be some charts here, you may need to enable JavaScript!
DB Assay description Assay Type Standard value Standard parameter Original value Original units Original parameter Reference
Dihydrofolate reductase in Plasmodium falciparum K1 (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1939] [UniProtKB: P13922]
ChEMBL Inhibition of wild type Plasmodium falciparum DHFR using DHF as substrate assessed as inhibition constant in presence of NADPH by UV-Vis spectrometry analysis B 9.37 pKi 0.43 nM Ki RSC Med Chem (2023) 14: 1755-1766 [PMID:37731689]
dihydrofolate reductase/Dihydrofolate reductase in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL202] [GtoPdb: 2603] [UniProtKB: P00374]
ChEMBL Inhibition of human DHFR using DHF as substrate assessed as inhibition constant in presence of NADPH by UV-Vis spectrometry analysis B 7.76 pKi 17.41 nM Ki RSC Med Chem (2023) 14: 1755-1766 [PMID:37731689]
Plasmodium falciparum (target type: ORGANISM) [ChEMBL: CHEMBL364]
ChEMBL Antiplasmodial activity against PYR-resistant Plasmodium falciparum V1/S encoding QM DHFR infected in human erythrocytes assessed as inhibition of parasite growth by [3H]-hypoxanthine incorporation assay F 7.25 pIC50 56 nM IC50 RSC Med Chem (2023) 14: 1755-1766 [PMID:37731689]
ChEMBL Antiplasmodial activity against PYR-sensitive Plasmodium falciparum TM4/8.2 encoding WT DHFR infected in human erythrocytes assessed as inhibition of parasite growth by [3H]-hypoxanthine incorporation assay F 8.3 pIC50 5 nM IC50 RSC Med Chem (2023) 14: 1755-1766 [PMID:37731689]
ChEMBL Antimalarial activity against wildtype Plasmodium falciparum TM4 F 8.34 pIC50 4.6 nM IC50 Eur J Med Chem (2021) 210: 112955-112955 [PMID:33131885]
ChEMBL Antimalarial activity against Plasmodium falciparum V1/S harboring DHFR N51I+C59R+S108N+I164L quadruple mutant assessed as reduction parasite growth by [3H]-hypoxanthine incorporation assay F 7.25 pEC50 56 nM EC50 Medchemcomm (2016) 7: 749-768
Plasmodium falciparum bifunctional dihydrofolate reductase-thymidylate synthase in Plasmodium falciparum TM4 [GtoPdb: 2981]
GtoPdb Parasite growth inhibition assay - 8.34 pIC50 4.6 nM IC50 Proc Natl Acad Sci USA (2012) 109: 16823-8 [PMID:23035243]
Plasmodium falciparum bifunctional dihydrofolate reductase-thymidylate synthase in Plasmodium falciparum [GtoPdb: 2981]
GtoPdb Parasite liver stage assay - 7.92 pEC50 <12 nM EC50 Nat Commun (2018) 9: 1837 [PMID:29743474]
Plasmodium falciparum bifunctional dihydrofolate reductase-thymidylate synthase in Plasmodium falciparum NF54 [GtoPdb: 2981]
GtoPdb Parasite exflagellation assay - 8.4 pIC50 4 nM IC50 Int J Parasitol (2021) 51: 635-642 [PMID:33713651]
Plasmodium falciparum bifunctional dihydrofolate reductase-thymidylate synthase in Plasmodium vivax [GtoPdb: 2981]
GtoPdb Parasite liver stage assay - 7.35 pEC50 45 nM EC50 Nat Commun (2018) 9: 1837 [PMID:29743474]

ChEMBL data shown on this page come from version 34:

Zdrazil B, Felix E, Hunter F, Manners EJ, Blackshaw J, Corbett S, de Veij M, Ioannidis H, Lopez DM, Mosquera JF, Magarinos MP, Bosc N, Arcila R, Kizilören T, Gaulton A, Bento AP, Adasme MF, Monecke P, Landrum GA, Leach AR. (2024). The ChEMBL Database in 2023: a drug discovery platform spanning multiple bioactivity data types and time periods. Nucleic Acids Res., 52(D1). DOI: 10.1093/nar/gkad1004. [EPMCID:10767899] [PMID:37933841]
Davies M, Nowotka M, Papadatos G, Dedman N, Gaulton A, Atkinson F, Bellis L, Overington JP. (2015) 'ChEMBL web services: streamlining access to drug discovery data and utilities.' Nucleic Acids Res., 43(W1). DOI: 10.1093/nar/gkv352. [EPMCID:25883136]